Transcatheter arterial micro-embolization for chronic post surgical pain after total knee arthroplasty

Not Applicable

Recruiting

• Conditions: Cronic post-surgical pain after total knee arthroplasty; total knee arthroplasty/ chronic post-surgical pain

• Registration Number: JPRN-jRCTs061220039
• Lead Sponsor: Sugimura Natsuki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-07-06
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Patients who meet all of the following criteria will be eligible.
(1) Patients who have undergone total knee arthroplasty (TKA) for osteoarthritis (OA) for at least one year at the time of consent.
(2) Patients with a pain VAS of 30 or higher at the time of consent.
(3) Patients whose age at the time of consent acquisition is between 50 and 90 years old.
(4) Patients with poor improvement after conservative therapy (NSAID patch, education, exercise therapy) for at least 3 months prior to obtaining consent (pain VAS 30 or higher).

Exclusion Criteria

Patients who meet at least one of the following criteria will be excluded from the study. Patients who meet any one of the following criteria will not be allowed to participate in this study.
(1) Patients with active indications for surgical treatment (e.g. aseptic loosening)
(2) Patients with any of the following conditions: infection, rheumatoid arthritis, or mental illness.
(3) Patients with poor alignment
(4) Patients with actively suspected pain due to spinal lesions
(5) Patients with a high psychogenic predisposition to pain
(6) Patients with poorly controlled diabetesmellitus
(7) Patients taking antithrombotic medication which can not be suspended
(8) Patients with severely impaired renal function
(9) Patients with bronchial asthma
(10) Patients taking biguanide hypoglycemic agents which can not be suspended
(11) Patients taking valproic acid
(12) Patients with allergy to IPM/CS or contrast media
(13) Patients who are difficult to follow up in the hospital for one year.
(14) Patients deemed ineligible by the physician.

Study & Design

• Study Type: Interventional
• Study Design: Not specified